Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2005 1
2008 1
2009 1
2010 3
2011 1
2018 1
2019 1
2020 1
2021 2
2022 1
2023 2
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

10 results

Results by year

Filters applied: . Clear all
Page 1
hENT1 as a Predictive Biomarker in PDAC-Response.
Perera S, Jang GH, Grant R, Notta F, Grunwald B, Gallinger S, Knox JJ, O'Kane GM. Perera S, et al. Clin Cancer Res. 2023 Aug 1;29(15):2945-2948. doi: 10.1158/1078-0432.CCR-23-0887. Clin Cancer Res. 2023. PMID: 37525960 No abstract available.
Molecular characterisation of pancreatic ductal adenocarcinoma with NTRK fusions and review of the literature.
Allen MJ, Zhang A, Bavi P, Kim JC, Jang GH, Kelly D, Perera S, Denroche RE, Notta F, Wilson JM, Dodd A, Ramotar S, Hutchinson S, Fischer SE, Grant RC, Gallinger S, Knox JJ, O'Kane GM. Allen MJ, et al. Among authors: perera s. J Clin Pathol. 2023 Mar;76(3):158-165. doi: 10.1136/jclinpath-2021-207781. Epub 2021 Sep 28. J Clin Pathol. 2023. PMID: 34583947 Review.
hENT1 Expression Predicts Response to Gemcitabine and Nab-Paclitaxel in Advanced Pancreatic Ductal Adenocarcinoma.
Perera S, Jang GH, Wang Y, Kelly D, Allen M, Zhang A, Denroche RE, Dodd A, Ramotar S, Hutchinson S, Tehfe M, Ramjeesingh R, Biagi J, Lam B, Wilson J, Fischer SE, Zogopoulos G, Notta F, Gallinger S, Grant RC, Knox JJ, O'Kane GM. Perera S, et al. Clin Cancer Res. 2022 Dec 1;28(23):5115-5120. doi: 10.1158/1078-0432.CCR-22-2576. Clin Cancer Res. 2022. PMID: 36222851